| Product Code: ETC10815382 | Publication Date: Apr 2025 | Updated Date: Nov 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | No. of Pages: 65 | No. of Figures: 34 | No. of Tables: 19 | |
In 2024, Portugal continued to heavily rely on imports of small molecule CDMO from countries like Spain, Netherlands, India, Metropolitan France, and Germany. Despite a high level of market concentration indicated by the Herfindahl-Hirschman Index (HHI), the industry experienced a significant decline with a Compound Annual Growth Rate (CAGR) of -21.25% from 2020 to 2024. This downward trend intensified in 2024 with a sharp growth rate decrease of -46.63% compared to the previous year, reflecting challenges and shifts in the market dynamics impacting import shipments in the sector.
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Portugal Small Molecule CDMO Market Overview |
3.1 Portugal Country Macro Economic Indicators |
3.2 Portugal Small Molecule CDMO Market Revenues & Volume, 2021 & 2031F |
3.3 Portugal Small Molecule CDMO Market - Industry Life Cycle |
3.4 Portugal Small Molecule CDMO Market - Porter's Five Forces |
3.5 Portugal Small Molecule CDMO Market Revenues & Volume Share, By Service Type, 2021 & 2031F |
3.6 Portugal Small Molecule CDMO Market Revenues & Volume Share, By API Type, 2021 & 2031F |
3.7 Portugal Small Molecule CDMO Market Revenues & Volume Share, By Drug Development Stage, 2021 & 2031F |
3.8 Portugal Small Molecule CDMO Market Revenues & Volume Share, By Facility Type, 2021 & 2031F |
3.9 Portugal Small Molecule CDMO Market Revenues & Volume Share, By Regulatory Compliance, 2021 & 2031F |
4 Portugal Small Molecule CDMO Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing demand for personalized medicine and specialty drugs requiring small molecule CDMO services |
4.2.2 Growth in outsourcing of pharmaceutical manufacturing to reduce costs and improve flexibility |
4.2.3 Favorable government policies and incentives supporting the pharmaceutical industry in Portugal |
4.3 Market Restraints |
4.3.1 Intense competition from established CDMO companies in other regions |
4.3.2 Regulatory challenges and compliance requirements impacting time-to-market for small molecule products |
5 Portugal Small Molecule CDMO Market Trends |
6 Portugal Small Molecule CDMO Market, By Types |
6.1 Portugal Small Molecule CDMO Market, By Service Type |
6.1.1 Overview and Analysis |
6.1.2 Portugal Small Molecule CDMO Market Revenues & Volume, By Service Type, 2021 - 2031F |
6.1.3 Portugal Small Molecule CDMO Market Revenues & Volume, By Drug Substance Development, 2021 - 2031F |
6.1.4 Portugal Small Molecule CDMO Market Revenues & Volume, By Drug Product Manufacturing, 2021 - 2031F |
6.1.5 Portugal Small Molecule CDMO Market Revenues & Volume, By Formulation Services, 2021 - 2031F |
6.1.6 Portugal Small Molecule CDMO Market Revenues & Volume, By Analytical Testing, 2021 - 2031F |
6.1.7 Portugal Small Molecule CDMO Market Revenues & Volume, By Packaging & Logistics, 2021 - 2031F |
6.2 Portugal Small Molecule CDMO Market, By API Type |
6.2.1 Overview and Analysis |
6.2.2 Portugal Small Molecule CDMO Market Revenues & Volume, By Generic APIs, 2021 - 2031F |
6.2.3 Portugal Small Molecule CDMO Market Revenues & Volume, By Specialty APIs, 2021 - 2031F |
6.2.4 Portugal Small Molecule CDMO Market Revenues & Volume, By Biotech APIs, 2021 - 2031F |
6.2.5 Portugal Small Molecule CDMO Market Revenues & Volume, By Oncology Drug APIs, 2021 - 2031F |
6.2.6 Portugal Small Molecule CDMO Market Revenues & Volume, By High-Potency APIs, 2021 - 2031F |
6.3 Portugal Small Molecule CDMO Market, By Drug Development Stage |
6.3.1 Overview and Analysis |
6.3.2 Portugal Small Molecule CDMO Market Revenues & Volume, By Early-Stage Discovery, 2021 - 2031F |
6.3.3 Portugal Small Molecule CDMO Market Revenues & Volume, By Preclinical Trials, 2021 - 2031F |
6.3.4 Portugal Small Molecule CDMO Market Revenues & Volume, By Clinical Trials Phase 1, 2021 - 2031F |
6.3.5 Portugal Small Molecule CDMO Market Revenues & Volume, By Commercial Manufacturing, 2021 - 2031F |
6.3.6 Portugal Small Molecule CDMO Market Revenues & Volume, By Post- Surveillance, 2021 - 2031F |
6.4 Portugal Small Molecule CDMO Market, By Facility Type |
6.4.1 Overview and Analysis |
6.4.2 Portugal Small Molecule CDMO Market Revenues & Volume, By Pilot Scale, 2021 - 2031F |
6.4.3 Portugal Small Molecule CDMO Market Revenues & Volume, By Large-Scale Production, 2021 - 2031F |
6.4.4 Portugal Small Molecule CDMO Market Revenues & Volume, By R&D Facilities, 2021 - 2031F |
6.4.5 Portugal Small Molecule CDMO Market Revenues & Volume, By Sterile Manufacturing Units, 2021 - 2031F |
6.4.6 Portugal Small Molecule CDMO Market Revenues & Volume, By Integrated Supply Chain Management, 2021 - 2031F |
6.5 Portugal Small Molecule CDMO Market, By Regulatory Compliance |
6.5.1 Overview and Analysis |
6.5.2 Portugal Small Molecule CDMO Market Revenues & Volume, By US FDA & EMA Approved, 2021 - 2031F |
6.5.3 Portugal Small Molecule CDMO Market Revenues & Volume, By GMP & ISO 13485 Certified, 2021 - 2031F |
6.5.4 Portugal Small Molecule CDMO Market Revenues & Volume, By WHO GMP Standards, 2021 - 2031F |
6.5.5 Portugal Small Molecule CDMO Market Revenues & Volume, By Good Laboratory Practices, 2021 - 2031F |
6.5.6 Portugal Small Molecule CDMO Market Revenues & Volume, By Hazardous Material Handling, 2021 - 2031F |
7 Portugal Small Molecule CDMO Market Import-Export Trade Statistics |
7.1 Portugal Small Molecule CDMO Market Export to Major Countries |
7.2 Portugal Small Molecule CDMO Market Imports from Major Countries |
8 Portugal Small Molecule CDMO Market Key Performance Indicators |
8.1 Capacity utilization rate of small molecule CDMO facilities in Portugal |
8.2 Rate of adoption of advanced technologies and automation in manufacturing processes |
8.3 Number of strategic partnerships and collaborations with pharmaceutical companies for small molecule development |
8.4 Percentage of revenue invested in research and development for innovative solutions in small molecule manufacturing |
8.5 Employee retention rate and level of expertise in small molecule CDMO sector |
9 Portugal Small Molecule CDMO Market - Opportunity Assessment |
9.1 Portugal Small Molecule CDMO Market Opportunity Assessment, By Service Type, 2021 & 2031F |
9.2 Portugal Small Molecule CDMO Market Opportunity Assessment, By API Type, 2021 & 2031F |
9.3 Portugal Small Molecule CDMO Market Opportunity Assessment, By Drug Development Stage, 2021 & 2031F |
9.4 Portugal Small Molecule CDMO Market Opportunity Assessment, By Facility Type, 2021 & 2031F |
9.5 Portugal Small Molecule CDMO Market Opportunity Assessment, By Regulatory Compliance, 2021 & 2031F |
10 Portugal Small Molecule CDMO Market - Competitive Landscape |
10.1 Portugal Small Molecule CDMO Market Revenue Share, By Companies, 2024 |
10.2 Portugal Small Molecule CDMO Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here